Skip to content
Use caution Drug recall · FDA · Published July 24, 2015

Combivent Respimat Recall: Defective Delivery System Hazard

Boehringer Ingelheim recalls Combivent Respimat inhalers due to defective delivery systems that may not spray properly. Check your lot number.

🇺🇸 FDA recall #D-1279-2015DrugCombivent Respimat ›
Take action

Contact the company

Recalling firmBoehringer Ingelheim Roxane Inc1809 Wilson Rd · Columbus, OH 43228-9579
✎ GovInfoNow plain-language explainer

Boehringer Ingelheim Roxane Inc is recalling Combivent Respimat Inhalation Spray because the delivery system is defective. The inhalers may emit no spray or only a short transient spray, potentially preventing users from receiving their medication. This recall affects 358,647 units distributed nationwide and in Puerto Rico. Read more at govinfonow.com/recall/43991-boehringer-ingelheim-roxane-inc-recalls-combivent-respimat-ipratropium-bromide-and.

Source Summary by GovInfoNow · govinfonow.com/recall/43991-boehringer-ingelheim-roxane-inc-recalls-combivent-respimat-ipratropium-bromide-and · Updated October 12, 2026 · FDA enforcement record: FDA #D-1279-2015

Cite this page

“Combivent Respimat Recall: Defective Delivery System Hazard.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/43991-boehringer-ingelheim-roxane-inc-recalls-combivent-respimat-ipratropium-bromide-and. Based on FDA recall #D-1279-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1279-2015%22&limit=1).

The FDA announced on July 24, 2015, that Boehringer Ingelheim Roxane Inc voluntarily recalled Combivent Respimat Inhalation Spray due to a defective delivery system. The hazard involves inhalers emitting no spray or a short transient spray instead of the proper dose.

How to tell if you have it

  • Brand: Combivent Respimat
  • Product: Combivent Respimat Inhalation Spray, 20 mcg/100 mcg per actuation*, 4 Grams, 120 Metered Doses
  • NDC: 0597-0024-02
  • Lot #: 408267, Exp 11/17
  • Distribution: Nationwide and Puerto Rico

The hazard

The recalled inhalers have a defective delivery system that causes them to spray improperly. This defect results in the device emitting either no spray or only a short transient spray.

Context

GovInfoNow's records show Boehringer Ingelheim Roxane Inc has 12 other recalls on record since 2012-11-05. Other recent recalls of similar products include Apotex Desmopressin Nasal Spray Recall (2026-04-08), ANI Pharmaceuticals Recalls Estradiol Gel (2026-05-12), and Synjardy XR Tablets Recall (2026-06-12).

How to tell if you have this one

Check if you have Combivent Respimat Inhalation Spray, 20 mcg/100 mcg per actuation, with 120 metered doses. Look for NDC 0597-0024-02 and Lot # 408267 with an expiration date of 11/17.

  • Brand
    Combivent Respimat
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Inhaler

    Verify if your Combivent Respimat inhaler has NDC 0597-0024-02 and Lot # 408267 expiring in 11/17.

  2. Contact Your Pharmacist

    If you have the recalled lot, contact your pharmacist or healthcare provider for instructions on replacement or return.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 18 months after the firm started it.

1. Firm started the recall: Jul 24, 201512. FDA classified it Class II: Jul 27, 201523. Published in FDA’s Enforcement Report: Aug 5, 201534. FDA terminated the recall: Feb 1, 2017420152017
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1279-2015 (July 24, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1279-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA